Abstract
Abnormalities of platelet aggregation in response to adenosine diphosphate in 56 patients with chronic liver disease correlated with impairment of hepatocellular function but not with the etiology of the liver disease. Platelet-poor plasma from some patients appeared to contain an inhibitor since, in cross-over studies, it reduced the degree of aggregation of control subjects. However, platelet-poor plasma from some other patients enhanced aggregation in controls, and this was thought to be due to the presence of fibrin monomer. In the majority of patients with severe liver disease, platelet function still appeared defective, even after exclusion of the effects of plasma, and was independent of the platelet count in peripheral venous blood. Since patient platelet volumes were smaller than those of controls, these findings might be explained by deficiency of the larger hemostatically active type of platelet as a consequence of either bone marrow failure or splenic sequestration.
Similar content being viewed by others
References
Mandel E, Lazerson J: Thombasthenia in liver disease. N Engl J Med 265:56–61, 1961
Thomas DP: Abnormalities of platelet aggregation in patients with alcoholic cirrhosis. Ann NY Acad Sci 201:243–250, 1972
Ballard HS, Marcus AJ: Platelet aggregation in portal cirrhosis. Arch Intern Med 136:316–319, 1976
Bull BS, Schneiderman MA, Brecher G: Platelet counts with the Coulter counter. Am J Clin Pathol 44:678–688, 1965
Manucci PM, Sharp AA: Platelet volume and shape in relation to aggregation and adhesion. Br J Haematol 13: 604–618, 1967
Mielke CH, Kaneshiro MM, Maher IA, Weinner JM, Rapaport SI: The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 34:204–215, 1969
Hardisty RM, Hutton RA: The kaolin clotting time of platelet-rich plasma: A test of platelet factor 3 availability. Br J Haematol 11:258–268, 1965
Dacie JV, Lewis SM: Practical Haematology, 5th edition. Edinburgh, Churchill Livingstone, 1975
Vermylen C, De Vreker RA, Verstraete M: A rapid enzymatic method for assay of fibrinogen fibrin polymerisation time (FPT test). Clin Chim Acta 8:418–425, 1963
Fletcher AP, Biederman O, Moore D, Alkjaersig N, Sherry S: Abnormal plasminogen-plasmin system activity (fibrinolysis) in patients with hepatic cirrhosis: Its cause and consequences. J Clin Invest 43:681–695, 1964
Kopec M, Budzynski A, Stachurska J, Wegrzynowicz Z, Kowalski E: Studies on mechanism of interference by fibrinogen degradation products (FDP) with platelet function: Role of fibrinogen in platelet atmosphere. Thromb Diath Haemorrh 15:476–490, 1966
Rubin MH, Weston MJ, Bullock G, Roberts J, Langley P, White YS, Williams R: Abnormal platelet function and ultrastructure in fulminant hepatic failure. Q J Med 183:339–352, 1977
Karpatkin S: Heterogeneity of human platelets. II Functional evidence suggestive of young and old platelets. J Clin Invest 48:1083–1087, 1969
Ginsburg AD, Aster RH: Changes associated with platelet aging. Thromb Diath Haemorrh 27:407–415, 1972
Karpatkin S: Heterogeneity of human platelets VI. correlation of platelet function with platelet volume. Blood 51:307–315, 1978
Shulman NR, Watkins SP, Itscoitz SB, Students AB: Evidence that the spleen retains the youngest and hemostatically most effective platelets. Trans Assoc Am Physicians 81:302–313, 1968
Freedman ML, Karpatkin S: Heterogeneity of rabbit platelets. V. Preferential splenic sequestration of megathrombocytes. Br J Haematol 31:255–262, 1975
Aster RH: Pooling of platelets in the spleen: Role in the pathogenesis of “hypersplenic thrombocytopenia.” J Clin Invest 15:645–657, 1966
Karpatkin S, Freedman ML: Hypersplenic thrombocytopenia differentiated from increased peripheral destruction by platelet volume. Ann Intern Med 89:200–203, 1978
Siemensma NP, Bathal PS, Penington DG: The effect of massive liver resection on platelet kinetics in the rat. J Lab Clin Med 86:817–833
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rubin, M.H., Weston, M.J., Langley, P.G. et al. Platelet function in chronic liver disease. Digest Dis Sci 24, 197–202 (1979). https://doi.org/10.1007/BF01308429
Issue Date:
DOI: https://doi.org/10.1007/BF01308429